Motilal Oswal lifts Zydus Wellness target to Rs 600, sees 26% revenue CAGR through FY28
Post Q4, Motilal Oswal reiterates Buy on Zydus Wellness, citing core portfolio stability plus RiteBite and Comfort Click acquisitions. Brokerage models 26% consolidated revenue CAGR and 37% Ebitda CAGR over FY26-28E, valuing the stock at 23x FY27 and 18x FY28 EV/Ebitda.
Post Q4, Motilal Oswal reiterates Buy on Zydus Wellness, citing core portfolio stability plus RiteBite and Comfort Click acquisitions. Brokerage models 26% cons
NDTV Profit · 5/19/2026, 3:15:26 AM · Ask about this →